Essentials_ Psychedelics for Treating Mental Disorders _ Dr. Matthew Johnson

January 15, 2026

AI Summary

5 min read

The Format: A structured interview in the Huberman Lab Essentials podcast series, revisiting science-based tools on psychedelics, blending deep pharmacology dives with therapeutic insights.
The Key Players:
- Guest: Dr. Matthew Johnson, psychedelics researcher at Johns Hopkins, renowned for clinical trials on psilocybin for depression, addiction, and end-of-life anxiety—pioneering peer-reviewed evidence in a once-taboo field.
- Host: Andrew Huberman, Stanford neuroscientist, probing with precise questions on mechanisms, drawing parallels to neuroplasticity and self-models.
The Vibe: Educational and intensely curious, with optimistic undertones on therapeutic breakthroughs, tempered by cautious realism on risks—feels like a masterclass for science enthusiasts.

Continue reading the full summary in the app — free to try.

Free • No credit card required

1 (00:00) **🎙️ Introduction: Dr. Matthew Johnson**
2 (01:40) **Psychedelic Nomenclature and Classes**
3 (05:16) **Defining Psychedelics: Altering Models and Sense of Self**
4 (08:41) **Serotonin System and Psychedelic Effects**
5 (10:46) **Clinical Trials Overview**
6 (11:34) **Screening, Preparation, and Session Protocol**
7 (14:28) **Letting Go, Trust, and Perceptual Expansion**

+ Full timestamped outline available in the app

Essentials_ Psychedelics for Treating Mental Disorders _ Dr. Matthew Johnson